Related Experiment Video
Updated: Aug 7, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
[Encephalopathy in children infected by vertically transmitted human immunodeficiency virus]
1Servicio de Neurología, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina. tominadia@hotmail.com
Insights
Antiretroviral treatment significantly improves neurological conditions in children with pediatric neuro-AIDS, reversing developmental delays and microcephaly. This offers hope for managing HIV-related brain complications in children.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Context:
- Pediatric neuro-AIDS affects a significant percentage of children with HIV/AIDS.
- Neurological involvement ranges from 30-70% clinically, up to 96% with pathological studies.
- Vertical transmission is a primary route of HIV infection in children.
Purpose:
- To present the epidemiology of pediatric neuro-AIDS in Argentina.
- To describe the clinical experience with 311 children diagnosed with neuro-AIDS.
- To evaluate the impact of antiretroviral treatment on neurological outcomes.
Summary:
- A study followed 784 vertically HIV-infected children, with 311 developing neuro-AIDS.
- Encephalopathy was present in 92% of neuro-AIDS cases, with CNS infections and bacterial infections being common.
- Antiretroviral therapy showed remarkable improvements in encephalopathy and microcephaly.
Impact:
- Antiretroviral treatment can lead to remission or significant improvement of encephalopathy.
- Treatment can moderate severe neuro-AIDS phenotypes, improving developmental outcomes.
- Reversal of acquired microcephaly is a notable treatment effect, with limited prior literature.
Introduction:
According to different authors, between 30% and 70% of children with AIDS clinically present some degree of neurological involvement. When including studies on pathology, the number increases to 96%.
Development:
We present the epidemiology of pediatric neuro-AIDS in Argentina and our experience in the follow-up of 784 HIV+ children infected by vertical transmission, of whom 311 developed neuro-AIDS. Of these children, 92% presented encephalopathy. In 29% of cases infection of the central nervous system was the hallmark of the disease followed by recurrent bacterial infection in 33%. The present series accounts for 25% of pediatric cases of HIV infection in the country.
Conclusions:
In our experience, the most remarkable results of antiretroviral treatment compared with natural evolution were: a) Ad integrum remission or noteworthy improvement of progressive and non-progressive encephalopathy, b) Conversion of the most severe cases of progressive encephalopathy (severe developmental delay, acquired microcephaly, spastic quadriparesis and fatal progression) into a more moderate phenotype (less developmental delay, normal head growth, spastic paraparesis and chronic evolution of the disease), and c) Reversion of acquired microcephaly observed in the first years of the epidemic, on which little has been published in the literature.
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Hepatic Encephalopathy
Cryptococcal Meningitis
Arboviral Encephalitis

